HEADER IMMUNE SYSTEM 16-NOV-22 8F6O TITLE ANTI-BTLA MONOCLONAL ANTIBODY H22B3 IN COMPLEX WITH BTLA COMPND MOL_ID: 1; COMPND 2 MOLECULE: H22B3 FAB HEAVY CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: H22B3 FAB LIGHT CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: B- AND T-LYMPHOCYTE ATTENUATOR; COMPND 11 CHAIN: C; COMPND 12 FRAGMENT: EXTRACELLULAR DOMAIN; COMPND 13 SYNONYM: B- AND T-LYMPHOCYTE-ASSOCIATED PROTEIN; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: BTLA; SOURCE 16 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 10029 KEYWDS MONOCLONAL ANTIBODY, COMPLEX, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.HENDLE,S.ATWELL,R.LIEU,M.HICKEY,K.WEICHERT REVDAT 4 25-OCT-23 8F6O 1 REMARK REVDAT 3 16-AUG-23 8F6O 1 JRNL REVDAT 2 05-JUL-23 8F6O 1 JRNL REVDAT 1 24-MAY-23 8F6O 0 JRNL AUTH T.C.CHEUNG,S.ATWELL,L.BAFETTI,P.D.CUENCA,K.FRONING,J.HENDLE, JRNL AUTH 2 M.HICKEY,C.HO,J.HUANG,R.LIEU,S.LIM,D.LIPPNER,V.OBUNGU, JRNL AUTH 3 L.WARD-KAVANAGH,K.WEICHERT,C.F.WARE,A.C.VENDEL JRNL TITL EPITOPE TOPOGRAPHY OF AGONIST ANTIBODIES TO THE CHECKPOINT JRNL TITL 2 INHIBITORY RECEPTOR BTLA. JRNL REF STRUCTURE V. 31 958 2023 JRNL REFN ISSN 0969-2126 JRNL PMID 37279757 JRNL DOI 10.1016/J.STR.2023.05.011 REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER V2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 31602 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4085 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 156 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4206 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5743 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1371 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 85 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 624 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4206 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 566 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4500 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.23 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.37 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.97 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8F6O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1000270090. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JUL-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97931 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31602 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.310 REMARK 200 RESOLUTION RANGE LOW (A) : 54.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.10 REMARK 200 R MERGE FOR SHELL (I) : 0.50500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2AW2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 23% PEG 10K + 200MM MAGNESIUM FORMATE REMARK 280 + 100MM SODIUM ACETATE PH 5.4, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 116.75000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 116.75000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 34.47500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 44.03000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 34.47500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 44.03000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 116.75000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 34.47500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 44.03000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 116.75000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 34.47500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 44.03000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A 225 REMARK 465 GLY A 226 REMARK 465 HIS A 227 REMARK 465 HIS A 228 REMARK 465 HIS A 229 REMARK 465 HIS A 230 REMARK 465 HIS A 231 REMARK 465 HIS A 232 REMARK 465 LYS C 31 REMARK 465 GLU C 32 REMARK 465 THR C 134 REMARK 465 ASP C 135 REMARK 465 VAL C 136 REMARK 465 LYS C 137 REMARK 465 SER C 138 REMARK 465 ALA C 139 REMARK 465 SER C 140 REMARK 465 GLU C 141 REMARK 465 ARG C 142 REMARK 465 PRO C 143 REMARK 465 SER C 144 REMARK 465 LYS C 145 REMARK 465 ASP C 146 REMARK 465 GLU C 147 REMARK 465 MET C 148 REMARK 465 ALA C 149 REMARK 465 SER C 150 REMARK 465 GLU C 151 REMARK 465 PHE C 152 REMARK 465 HIS C 153 REMARK 465 HIS C 154 REMARK 465 HIS C 155 REMARK 465 HIS C 156 REMARK 465 HIS C 157 REMARK 465 HIS C 158 REMARK 465 HIS C 159 REMARK 465 HIS C 160 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 224 CG CD CE NZ REMARK 470 ARG B 77 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 129 CD CE NZ REMARK 470 SER C 33 OG REMARK 470 ILE C 48 CG1 CG2 CD1 REMARK 470 LEU C 49 CG CD1 CD2 REMARK 470 GLU C 55 CG CD OE1 OE2 REMARK 470 LYS C 61 CG CD CE NZ REMARK 470 TYR C 62 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASN C 65 CG OD1 ND2 REMARK 470 ARG C 66 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 91 CG CD OE1 OE2 REMARK 470 LYS C 93 CG CD CE NZ REMARK 470 ASN C 94 CG OD1 ND2 REMARK 470 LEU C 106 CG CD1 CD2 REMARK 470 ASN C 108 CG OD1 ND2 REMARK 470 ASN C 118 CG OD1 ND2 REMARK 470 GLN C 120 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 52 -176.05 -63.07 REMARK 500 SER B 30 -122.66 51.28 REMARK 500 LEU B 47 -67.86 -105.18 REMARK 500 ALA B 51 -36.80 63.00 REMARK 500 LEU B 78 100.09 -44.71 REMARK 500 ASN B 141 75.96 47.16 REMARK 500 TYR C 39 52.48 -103.03 REMARK 500 ALA C 64 -156.18 -96.75 REMARK 500 ARG C 66 121.08 -26.88 REMARK 500 ASP C 84 75.63 39.16 REMARK 500 GLU C 92 -162.94 -122.05 REMARK 500 LYS C 93 -95.97 -63.88 REMARK 500 ASN C 108 32.20 -82.79 REMARK 500 PHE C 119 -73.76 -131.28 REMARK 500 GLN C 120 37.36 -80.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8F60 RELATED DB: PDB REMARK 900 8F60 CONTAINS A RELATED ANTIBODY PROTEIN DBREF 8F6O A 1 232 PDB 8F6O 8F6O 1 232 DBREF 8F6O B 1 217 PDB 8F6O 8F6O 1 217 DBREF 8F6O C 31 150 UNP Q7Z6A9 BTLA_HUMAN 31 150 SEQADV 8F6O GLU C 151 UNP Q7Z6A9 EXPRESSION TAG SEQADV 8F6O PHE C 152 UNP Q7Z6A9 EXPRESSION TAG SEQADV 8F6O HIS C 153 UNP Q7Z6A9 EXPRESSION TAG SEQADV 8F6O HIS C 154 UNP Q7Z6A9 EXPRESSION TAG SEQADV 8F6O HIS C 155 UNP Q7Z6A9 EXPRESSION TAG SEQADV 8F6O HIS C 156 UNP Q7Z6A9 EXPRESSION TAG SEQADV 8F6O HIS C 157 UNP Q7Z6A9 EXPRESSION TAG SEQADV 8F6O HIS C 158 UNP Q7Z6A9 EXPRESSION TAG SEQADV 8F6O HIS C 159 UNP Q7Z6A9 EXPRESSION TAG SEQADV 8F6O HIS C 160 UNP Q7Z6A9 EXPRESSION TAG SEQRES 1 A 232 PCA VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 A 232 PRO GLY ALA SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 A 232 PHE SER LEU SER SER TYR GLY VAL SER TRP VAL ARG GLN SEQRES 4 A 232 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY ALA ILE SER SEQRES 5 A 232 TYR ASP GLY ILE THR TYR TYR ALA SER TRP ALA LYS SER SEQRES 6 A 232 ARG VAL THR MET THR ARG ASP THR SER THR SER THR VAL SEQRES 7 A 232 TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR ALA SEQRES 8 A 232 VAL TYR TYR CYS ALA ARG GLY ASP TYR TYR ASP ASP TYR SEQRES 9 A 232 VAL TYR VAL TYR ALA LEU ASP ILE TRP GLY GLN GLY THR SEQRES 10 A 232 LEU VAL THR VAL SER SER ALA SER THR LYS GLY PRO SER SEQRES 11 A 232 VAL PHE PRO LEU ALA PRO CYS SER ARG SER THR SER GLU SEQRES 12 A 232 SER THR ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE SEQRES 13 A 232 PRO GLU PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU SEQRES 14 A 232 THR SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SEQRES 15 A 232 SER GLY LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SEQRES 16 A 232 SER SER SER LEU GLY THR LYS THR TYR THR CYS ASN VAL SEQRES 17 A 232 ASP HIS LYS PRO SER ASN THR LYS VAL ASP LYS ARG VAL SEQRES 18 A 232 GLU SER LYS TYR GLY HIS HIS HIS HIS HIS HIS SEQRES 1 B 217 GLU ILE VAL LEU THR GLN SER PRO GLY THR LEU SER LEU SEQRES 2 B 217 SER PRO GLY GLU ARG ALA THR LEU SER CYS GLN ALA SER SEQRES 3 B 217 GLN SER ILE SER THR ALA LEU ALA TRP TYR GLN GLN LYS SEQRES 4 B 217 PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR ALA ALA SER SEQRES 5 B 217 THR LEU ALA SER GLY ILE PRO ASP ARG PHE SER GLY SER SEQRES 6 B 217 GLY SER GLY THR ASP PHE THR LEU THR ILE SER ARG LEU SEQRES 7 B 217 GLU PRO GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN GLY SEQRES 8 B 217 TYR SER SER SER ASN LEU ASP ASN VAL PHE GLY GLY GLY SEQRES 9 B 217 THR LYS VAL GLU ILE LYS ARG THR VAL ALA ALA PRO SER SEQRES 10 B 217 VAL PHE ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER SEQRES 11 B 217 GLY THR ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR SEQRES 12 B 217 PRO ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA SEQRES 13 B 217 LEU GLN SER GLY ASN SER GLN GLU SER VAL THR GLU GLN SEQRES 14 B 217 ASP SER LYS ASP SER THR TYR SER LEU SER SER THR LEU SEQRES 15 B 217 THR LEU SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR SEQRES 16 B 217 ALA CYS GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL SEQRES 17 B 217 THR LYS SER PHE ASN ARG GLY GLU CYS SEQRES 1 C 130 LYS GLU SER CYS ASP VAL GLN LEU TYR ILE LYS ARG GLN SEQRES 2 C 130 SER GLU HIS SER ILE LEU ALA GLY ASP PRO PHE GLU LEU SEQRES 3 C 130 GLU CYS PRO VAL LYS TYR CYS ALA ASN ARG PRO HIS VAL SEQRES 4 C 130 THR TRP CYS LYS LEU ASN GLY THR THR CYS VAL LYS LEU SEQRES 5 C 130 GLU ASP ARG GLN THR SER TRP LYS GLU GLU LYS ASN ILE SEQRES 6 C 130 SER PHE PHE ILE LEU HIS PHE GLU PRO VAL LEU PRO ASN SEQRES 7 C 130 ASP ASN GLY SER TYR ARG CYS SER ALA ASN PHE GLN SER SEQRES 8 C 130 ASN LEU ILE GLU SER HIS SER THR THR LEU TYR VAL THR SEQRES 9 C 130 ASP VAL LYS SER ALA SER GLU ARG PRO SER LYS ASP GLU SEQRES 10 C 130 MET ALA SER GLU PHE HIS HIS HIS HIS HIS HIS HIS HIS HET PCA A 1 8 HETNAM PCA PYROGLUTAMIC ACID FORMUL 1 PCA C5 H7 N O3 FORMUL 4 HOH *156(H2 O) HELIX 1 AA1 ARG A 86 THR A 90 5 5 HELIX 2 AA2 SER A 166 ALA A 168 5 3 HELIX 3 AA3 LYS A 211 ASN A 214 5 4 HELIX 4 AA4 GLU B 79 PHE B 83 5 5 HELIX 5 AA5 SER B 124 LYS B 129 1 6 HELIX 6 AA6 LYS B 186 GLU B 190 1 5 HELIX 7 AA7 LEU C 106 ASN C 110 5 5 SHEET 1 AA1 4 GLN A 3 GLN A 6 0 SHEET 2 AA1 4 VAL A 18 SER A 25 -1 O LYS A 23 N VAL A 5 SHEET 3 AA1 4 THR A 77 LEU A 82 -1 O MET A 80 N VAL A 20 SHEET 4 AA1 4 VAL A 67 ASP A 72 -1 N THR A 68 O GLU A 81 SHEET 1 AA2 6 GLU A 10 LYS A 12 0 SHEET 2 AA2 6 THR A 117 VAL A 121 1 O THR A 120 N LYS A 12 SHEET 3 AA2 6 ALA A 91 ASP A 99 -1 N TYR A 93 O THR A 117 SHEET 4 AA2 6 GLY A 33 GLN A 39 -1 N SER A 35 O ALA A 96 SHEET 5 AA2 6 LEU A 45 ILE A 51 -1 O GLY A 49 N TRP A 36 SHEET 6 AA2 6 THR A 57 TYR A 59 -1 O TYR A 58 N ALA A 50 SHEET 1 AA3 4 GLU A 10 LYS A 12 0 SHEET 2 AA3 4 THR A 117 VAL A 121 1 O THR A 120 N LYS A 12 SHEET 3 AA3 4 ALA A 91 ASP A 99 -1 N TYR A 93 O THR A 117 SHEET 4 AA3 4 ALA A 109 TRP A 113 -1 O ALA A 109 N ASP A 99 SHEET 1 AA4 4 SER A 130 LEU A 134 0 SHEET 2 AA4 4 THR A 145 TYR A 155 -1 O GLY A 149 N LEU A 134 SHEET 3 AA4 4 TYR A 186 PRO A 195 -1 O TYR A 186 N TYR A 155 SHEET 4 AA4 4 VAL A 173 THR A 175 -1 N HIS A 174 O VAL A 191 SHEET 1 AA5 4 SER A 130 LEU A 134 0 SHEET 2 AA5 4 THR A 145 TYR A 155 -1 O GLY A 149 N LEU A 134 SHEET 3 AA5 4 TYR A 186 PRO A 195 -1 O TYR A 186 N TYR A 155 SHEET 4 AA5 4 VAL A 179 LEU A 180 -1 N VAL A 179 O SER A 187 SHEET 1 AA6 3 THR A 161 TRP A 164 0 SHEET 2 AA6 3 THR A 205 HIS A 210 -1 O ASN A 207 N SER A 163 SHEET 3 AA6 3 THR A 215 ARG A 220 -1 O THR A 215 N HIS A 210 SHEET 1 AA7 4 LEU B 4 SER B 7 0 SHEET 2 AA7 4 ALA B 19 ALA B 25 -1 O GLN B 24 N THR B 5 SHEET 3 AA7 4 ASP B 70 ILE B 75 -1 O ILE B 75 N ALA B 19 SHEET 4 AA7 4 PHE B 62 SER B 67 -1 N SER B 63 O THR B 74 SHEET 1 AA8 6 THR B 10 LEU B 13 0 SHEET 2 AA8 6 THR B 105 ILE B 109 1 O LYS B 106 N LEU B 11 SHEET 3 AA8 6 VAL B 85 GLN B 90 -1 N TYR B 86 O THR B 105 SHEET 4 AA8 6 LEU B 33 GLN B 38 -1 N GLN B 38 O VAL B 85 SHEET 5 AA8 6 ARG B 45 TYR B 49 -1 O LEU B 47 N TRP B 35 SHEET 6 AA8 6 THR B 53 LEU B 54 -1 O THR B 53 N TYR B 49 SHEET 1 AA9 4 SER B 117 PHE B 121 0 SHEET 2 AA9 4 THR B 132 PHE B 142 -1 O ASN B 140 N SER B 117 SHEET 3 AA9 4 TYR B 176 SER B 185 -1 O LEU B 182 N VAL B 135 SHEET 4 AA9 4 SER B 162 VAL B 166 -1 N GLN B 163 O THR B 181 SHEET 1 AB1 4 ALA B 156 LEU B 157 0 SHEET 2 AB1 4 ALA B 147 VAL B 153 -1 N VAL B 153 O ALA B 156 SHEET 3 AB1 4 VAL B 194 HIS B 201 -1 O THR B 200 N LYS B 148 SHEET 4 AB1 4 VAL B 208 ASN B 213 -1 O VAL B 208 N VAL B 199 SHEET 1 AB2 4 GLN C 37 LEU C 38 0 SHEET 2 AB2 4 PHE C 54 LYS C 61 -1 O LYS C 61 N GLN C 37 SHEET 3 AB2 4 SER C 96 PHE C 102 -1 O PHE C 102 N PHE C 54 SHEET 4 AB2 4 THR C 87 GLU C 91 -1 N SER C 88 O ILE C 99 SHEET 1 AB3 5 GLU C 45 SER C 47 0 SHEET 2 AB3 5 THR C 129 TYR C 132 1 O TYR C 132 N HIS C 46 SHEET 3 AB3 5 GLY C 111 ASN C 118 -1 N TYR C 113 O THR C 129 SHEET 4 AB3 5 VAL C 69 ASN C 75 -1 N CYS C 72 O ARG C 114 SHEET 5 AB3 5 THR C 78 LYS C 81 -1 O THR C 78 N ASN C 75 SHEET 1 AB4 4 GLU C 45 SER C 47 0 SHEET 2 AB4 4 THR C 129 TYR C 132 1 O TYR C 132 N HIS C 46 SHEET 3 AB4 4 GLY C 111 ASN C 118 -1 N TYR C 113 O THR C 129 SHEET 4 AB4 4 LEU C 123 GLU C 125 -1 O ILE C 124 N ALA C 117 SSBOND 1 CYS A 22 CYS A 95 1555 1555 2.03 SSBOND 2 CYS A 137 CYS B 217 1555 1555 2.04 SSBOND 3 CYS A 150 CYS A 206 1555 1555 2.03 SSBOND 4 CYS B 23 CYS B 88 1555 1555 2.07 SSBOND 5 CYS B 137 CYS B 197 1555 1555 2.04 SSBOND 6 CYS C 34 CYS C 63 1555 1555 2.04 SSBOND 7 CYS C 58 CYS C 115 1555 1555 2.03 SSBOND 8 CYS C 72 CYS C 79 1555 1555 2.04 LINK C PCA A 1 N VAL A 2 1555 1555 1.35 CISPEP 1 PHE A 156 PRO A 157 0 -4.44 CISPEP 2 GLU A 158 PRO A 159 0 -1.27 CISPEP 3 SER B 7 PRO B 8 0 -5.17 CISPEP 4 TYR B 143 PRO B 144 0 2.49 CISPEP 5 GLU C 103 PRO C 104 0 -1.69 CRYST1 68.950 88.060 233.500 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014503 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011356 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004283 0.00000 HETATM 1 N PCA A 1 1.473 -1.263 -40.484 1.00 63.42 N HETATM 2 CA PCA A 1 0.237 -1.466 -41.251 1.00 62.54 C HETATM 3 CB PCA A 1 0.070 -3.034 -41.157 1.00 63.88 C HETATM 4 CG PCA A 1 0.745 -3.391 -39.795 1.00 63.93 C HETATM 5 CD PCA A 1 1.588 -2.174 -39.484 1.00 64.00 C HETATM 6 OE PCA A 1 2.262 -2.042 -38.483 1.00 64.94 O HETATM 7 C PCA A 1 -0.976 -0.698 -40.662 1.00 61.38 C HETATM 8 O PCA A 1 -0.801 0.283 -39.931 1.00 60.08 O